Business News, stay in the loop
Milestones, appointments, partnerships, investors & more
Reacta Healthcare announces successful completion of £1m food allergy paediatric diagnostics project substantially funded by Innovate UK.
Reacta Healthcare announces successful completion of £1m food allergy paediatric diagnostics project substantially funded by Innovate UK. Reacta Healthcare, a clinical diagnostic company dedicated to providing innovative diagnostics for life-threatening food...
Reacta Healthcare strengthens Advisory Board in preparation for significant R&D and regulatory activities.
Reacta Healthcare strengthens Advisory Board in preparation for significant R&D and regulatory activities Reacta Healthcare’s Advisory Board brings a wealth of knowledge and expertise to the business, ensuring that the company objectives are aligned to our...
Simon Thelwall-Jones appointed as CFO
Simon Thelwall-Jones appointed as CFO Reacta Healthcare Press Release – 23 November 2023 Reacta Healthcare bolsters Board & Executive Team with the appointment of Simon Thelwall-Jones as Chief Financial Officer. In line with the company growth strategy and...
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs Posted on June 27, 2023 Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs Mr. Hawkins is a pharma veteran with leadership experience spanning R&D, regulatory affairs,...
New partnership with FAACT – Food Allergy & Anaphylaxis Connection Team
New partnership with FAACT – Food Allergy & Anaphylaxis Connection Team Posted on June 21, 2023Reacta Healthcare is proud to partner with FAACT to support the needs of the food allergy community. FAACT’s mission is to educate, advocate, and raise awareness for all...
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project Posted on February 10, 2023 Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater research and clinical practice in children to...
Senior hire to cement 2023 growth plans at Reacta Healthcare
Senior hire to cement 2023 growth plans at Reacta Healthcare Posted on January 20, 2023 Reacta Healthcare has appointed a new quality control manager to further expand and develop its quality function. The leadership post will ensure delivery of the company’s growth...
My time at MEDICA 2022
My time at MEDICA 2022 Posted on December 9, 2022 By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the privilege of not only attending but presenting at MEDICA, the world’s largest event for the medical sector. It’s so inspiring...
Development Bank of Wales ramping up tech equity deals since the lockdown
Development Bank of Wales ramping up tech equity deals since the lockdown Posted on September 12, 2022The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most promising tech-focused start-ups over a ten week period since the pandemic...
Reacta Healthcare secures first US patent
Reacta Healthcare secures first US patent Posted on August 8, 2022The patent has been granted for challenge meals, which are used in oral food challenges (OFCs). Unique to the Reacta formulation is Reacta’s ability to create a non-allergen formulation that is...